CLINICAL_TRIALS
trial_result
· 2008-10-10
Clinical Trial Update: Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide [Phase 3]
Summary
Phase 3 open-label trial evaluating Miglitol added to biguanide therapy in Type 2 Diabetes Mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED